Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 2012 Assets Cash Accounts receivable (net) $251,660 91,170 257,350 $235,180 84,470 250,070 96,890 Inventories Investments 0 Land 221,100 Equipment Accumulated depreciation equipment 132,000 283,950 (66,480) $949,650 (59,620) $828,090 Total assets Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Accrued expenses payable (operating expenses) $171,890 17,090 9,500 $163,130 21,530 7,450 40,580 Dividends payable Common stock, $10 par Paid-in capital: Excess of issue price over par-common stock Retained earnings 51,280 192,780 507,110 112,620 482,780 Total liabilities and stockholders' equity $949,650 $828,090 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: a. The investments were sold for $113,360 cash. b. Equipment and land were acquired for cash. c. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $63,250 credit to Retained Earnings for net income. f. There was a $38,920 debit to Retained Earnings for cash dividends declared. Required: Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments. Livers Inc. Statement of Cash Flows For the Year Ended December 31, 2043 Cash flows from operating activities: Adjustments to reconcile net income to net cash flow from operating activities: Changes in current operating assets and liabilities: DO 20 D1 000 Net cash flow from operating activities Cash flows from investing activities: Net cash flow used for investing activities Cash flows from financing activities: Net cash flow from financing activities Cash at the beginning of the year Cash at the end of the year